Guerbet Overview
Pro stress-test →Guerbet is a global pharmaceutical company specializing in medical imaging contrast agents and solutions for diagnostic radiology and interventional radiology. As a leading provider in contrast media for CT, MRI, and X-ray procedures, Guerbet serves hospitals and imaging centers worldwide with innovative products that enhance diagnostic visibility and patient outcomes.
Strategic Profile
Pro stress-test →Guerbet maintains a strong competitive position through its extensive portfolio of contrast agent products and its global distribution network. The company focuses on innovation in imaging solutions, digital connectivity, and international expansion, particularly in high-growth emerging markets to drive sustainable growth.
Competitive Landscape
Pro stress-test →Guerbet competes primarily against Bayer's Radiology division and other specialized pharmaceutical companies in contrast media. Its competitive advantages include deep expertise in imaging, established hospital relationships, and a comprehensive product portfolio that spans multiple imaging modalities.
Industry Context
Guerbet operates in Pharmaceutical (Specialty) - Medical Imaging & Diagnostic Solutions.
Key facts
Founded: 1926 · Headquarters: Villepinte, France · Employees: 4,100 · Revenue: €838M · Market cap: ~€1.2B